Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis

Yanan Zhao, Padmaja Paderu, Radha Railkar, Cameron Douglas, Robert Iannone, Norah Shire, David S. Perlin

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

A critical challenge for the successful application of antifungal therapies for invasive aspergillosis (IA) is a lack of reliable biomarkers to assess early treatment response. Patients with proven or probable IA were prospectively enrolled, and serial blood samples were collected at 8 specified time points during 12-week antifungal therapy. Total nucleic acid was extracted from 2.5 ml blood and tested for Aspergillus-specific RNA by a pan- Aspergillus real-time nucleic acid sequence-based amplification (NASBA) assay. Serum 1, 3-β-D-glucan (BG) and galactomannan (GM) were measured in parallel. Clinical outcome was evaluated at 6 and 12 weeks. Overall, 48/328 (14.6%) blood samples from 29/46 (63%) patients had positive NASBA detection at baseline and/or some point during the study. Positive NASBA results during the first 4 and 6 weeks of treatment are significantly associated with the 12-week outcome. Blood RNA load change during weeks 4-6 may be informative to predict outcome at 12 weeks. While independent of serum GM, the kinetic change of circulating Aspergillus RNA appears to be well correlated with that of BG on some patient individuals.Monitoring blood Aspergillus RNA during the first 4-6 weeks of antifungal treatment may help assess therapeutic response. Combination of circulating Aspergillus RNA and BG may be a useful adjunct to assess response.

Original languageEnglish (US)
Pages (from-to)801-807
Number of pages7
JournalMedical mycology
Volume54
Issue number8
DOIs
StatePublished - Nov 1 2016

All Science Journal Classification (ASJC) codes

  • Infectious Diseases

Keywords

  • Antifungal therapy
  • Aspergillus RNA
  • Biomarker
  • Invasive aspergillosis
  • NASBA

Fingerprint Dive into the research topics of 'Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis'. Together they form a unique fingerprint.

  • Cite this